Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Cell Chemical Biology
|
December 19, 2017
Objective, Quantitative, Data-Driven Assessment of Chemical Probes
Albert A Antolin, Joseph E Tym, Angeliki Komianou, et al.
Journal of Cheminformatics
|
June 1, 2022
canSAR chemistry registration and standardization pipeline
Daniela Dolciami, Eloy Villasclaras-Fernandez, Christos Kannas, et al.
Scientific Reports
|
February 19, 2020
The kinase polypharmacology landscape of clinical PARP inhibitors
Albert A Antolin, Malaka Ameratunga, Udai Banerji, et al.
Journal of Molecular Graphics & Modelling
|
September 24, 2013
Exploring the effect of PARP-1 flexibility in docking studies
Albert A Antolin, Andrea Carotti, Roberto Nuti, et al.
The Science of the Total Environment
|
December 16, 2023
Short-term exposure to environmental levels of nicotine and cotinine impairs visual motor response in zebrafish larvae through a similar mode of action: Exploring the potential role of zebrafish α7 nAChR
Marina Bellot, Leticia Manen, Eva Prats, et al.
Nucleic Acids Research
|
December 18, 2015
canSAR: an updated cancer research and drug discovery knowledgebase
Joseph E Tym, Costas Mitsopoulos, Elizabeth A Coker, et al.
European Journal of Medicinal Chemistry
|
January 6, 2026
Promiscuously bioactive compounds are prevalent in widely used commercial drug repurposing libraries
Huabin Hu, James Bowers, Justin Shumate, et al.
Nucleic Acids Research
|
November 18, 2024
The Chemical Probes Portal - 2024: update on this public resource to support best-practice selection and use of small molecules in biomedical research
Domenico Sanfelice, Albert A Antolin, Alisa Crisp, et al.
Cell Chemical Biology
|
February 9, 2024
Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite
Huabin Hu, Carme Serra, Wenjie Zhang, et al.
Clinical and Translational Medicine
|
April 17, 2024
Computational repurposing of oncology drugs through off-target drug binding interactions from pharmacological databases
Imogen R Walpole, Farzana Y Zaman, Peinan Zhao, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Cell Chemical Biology
|
December 19, 2017
Objective, Quantitative, Data-Driven Assessment of Chemical Probes
Albert A Antolin, Joseph E Tym, Angeliki Komianou, et al.
Journal of Cheminformatics
|
June 1, 2022
canSAR chemistry registration and standardization pipeline
Daniela Dolciami, Eloy Villasclaras-Fernandez, Christos Kannas, et al.
Scientific Reports
|
February 19, 2020
The kinase polypharmacology landscape of clinical PARP inhibitors
Albert A Antolin, Malaka Ameratunga, Udai Banerji, et al.
Journal of Molecular Graphics & Modelling
|
September 24, 2013
Exploring the effect of PARP-1 flexibility in docking studies
Albert A Antolin, Andrea Carotti, Roberto Nuti, et al.
The Science of the Total Environment
|
December 16, 2023
Short-term exposure to environmental levels of nicotine and cotinine impairs visual motor response in zebrafish larvae through a similar mode of action: Exploring the potential role of zebrafish α7 nAChR
Marina Bellot, Leticia Manen, Eva Prats, et al.
Nucleic Acids Research
|
December 18, 2015
canSAR: an updated cancer research and drug discovery knowledgebase
Joseph E Tym, Costas Mitsopoulos, Elizabeth A Coker, et al.
European Journal of Medicinal Chemistry
|
January 6, 2026
Promiscuously bioactive compounds are prevalent in widely used commercial drug repurposing libraries
Huabin Hu, James Bowers, Justin Shumate, et al.
Nucleic Acids Research
|
November 18, 2024
The Chemical Probes Portal - 2024: update on this public resource to support best-practice selection and use of small molecules in biomedical research
Domenico Sanfelice, Albert A Antolin, Alisa Crisp, et al.
Cell Chemical Biology
|
February 9, 2024
Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite
Huabin Hu, Carme Serra, Wenjie Zhang, et al.
Clinical and Translational Medicine
|
April 17, 2024
Computational repurposing of oncology drugs through off-target drug binding interactions from pharmacological databases
Imogen R Walpole, Farzana Y Zaman, Peinan Zhao, et al.
Page
of 3